These metabolite disruptions predispose Mof+/− mice to developing metabolic disorders, as confirmed by physiological indicators including impaired glucose assimilation, reduced insulin secretion and elevated glycated-hemoglobin (Hb1ac) levels in these animals. The gene discussed is KAT8; the disease is metabolic disease.